Correlation Between Bank Central and Pharma-Bio Serv

Can any of the company-specific risk be diversified away by investing in both Bank Central and Pharma-Bio Serv at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank Central and Pharma-Bio Serv into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bank Central Asia and Pharma Bio Serv, you can compare the effects of market volatilities on Bank Central and Pharma-Bio Serv and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank Central with a short position of Pharma-Bio Serv. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank Central and Pharma-Bio Serv.

Diversification Opportunities for Bank Central and Pharma-Bio Serv

0.38

Correlation Coefficient

Bank Central  Pharma-Bio Serv

Weak diversification

The 3 months correlation between Bank and Pharma-Bio is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Bank Central Asia and Pharma Bio Serv in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharma Bio Serv and Bank Central is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank Central Asia are associated (or correlated) with Pharma-Bio Serv. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharma Bio Serv has no effect on the direction of Bank Central i.e., Bank Central and Pharma-Bio Serv go up and down completely randomly.

Pair Corralation between Bank Central and Pharma-Bio Serv

Assuming the 90 days horizon Bank Central Asia is expected to generate 0.35 times more return on investment than Pharma-Bio Serv. However, Bank Central Asia is 2.84 times less risky than Pharma-Bio Serv. It trades about -0.09 of its potential returns per unit of risk. Pharma Bio Serv is currently generating about -0.03 per unit of risk. If you would invest  1,461  in Bank Central Asia on December 27, 2024 and sell it today you would lose (183.00) from holding Bank Central Asia or give up 12.53% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.36%
Values	Daily Returns

Bank Central Asia  vs.  Pharma Bio Serv

Bank Central Asia

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bank Central Asia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pharma Bio Serv

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pharma Bio Serv has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Bank Central and Pharma-Bio Serv

The main advantage of trading using opposite Bank Central and Pharma-Bio Serv positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank Central position performs unexpectedly, Pharma-Bio Serv can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharma-Bio Serv will offset losses from the drop in Pharma-Bio Serv's long position.

The idea behind Bank Central Asia and Pharma Bio Serv pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.